← Human Trials & Peer-Reviewed Studies
Association Between Intravenous Magnesium Therapy in the Emergency Department and Subsequent Hospitalization Among Pediatric Patients With Refractory Acute Asthma: Secondary Analysis of a Randomized Clinical Trial.
Plain-language guide to PMID 34279646 (2021): double-blind randomized controlled trial of Vitamin D, K2, Magnesium and Zinc in 816 children.
Key Facts
- PMID
- 34279646
- Journal
- JAMA network open
- Year
- 2021
- Study type
- Randomized Controlled Trial
- Authors
- Schuh S et al. (16 authors)
- DOI
- 10.1001/jamanetworkopen.2021.17542
- Registered trial
- NCT01429415
What This Study Did, in Plain Language
What Was Tested
This randomized controlled trial looks at Vitamin D, K2, Magnesium and Zinc.
To examine the association between IV magnesium therapy administered in the emergency department (ED) and subsequent hospitalization among pediatric patients with refractory acute asthma after adjustment for patient-level variables.
Who Took Part
The study group was 816 children.
PubMed indexes the participants as young children, children and teenagers, both men and women.
This post hoc secondary analysis of a double-blind randomized clinical trial of children with acute asthma treated from September 26, 2011, to November 19, 2019, at 7 Canadian tertiary care pediatric EDs was conducted between September and November 2020.
How the Study Was Run
The design is described as randomized, double-blind and placebo-controlled.
Random assignment meant chance, not the researchers, decided who got Vitamin D, K2, Magnesium and Zinc and who got the comparison, which limits bias.
Blinding on both sides kept the children and researchers unaware of who received Vitamin D, K2, Magnesium and Zinc.
The comparison arm used a placebo, so changes seen with Vitamin D, K2, Magnesium and Zinc could be set against what happens without it.
What Was Measured
The subject headings attached to it are Acute Disease, Administration, Inhalation, Administration, Intravenous, Albuterol, Anti-Asthmatic Agents, Asthma and Canada.
What This Means in Plain Language
The paper is a randomized, double-blind and placebo-controlled study of Vitamin D, K2, Magnesium and Zinc in 816 children.
With several hundred people or more, it is a fairly large study for this kind of research.
Results are reported in around 9 sentences of the abstract; we leave them to the paper itself rather than summarise them.
The publication is from 2021 (JAMA network open), a journal based in United States.
More context: the Vitamin D, K2, Magnesium and Zinc compound page, all human trials.
Our Notes on the Compound
Vitamin D, K2, Magnesium and Zinc: Magnesium is described as required for AMPK to function.
Related Pages
Source: PubMed record. This explanation is written by PeptideWhiz from the public record. For research and education only. Not medical advice; no dosing information is given.